We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aortech International Plc | LSE:AOR | London | Ordinary Share | GB0033360586 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 126.50 | 123.00 | 130.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
19/2/2020 10:15 | Great Note! SIX POUNDs SEVENTY SIX PENCE PER SHARE!!!!!!!!!!!!!!! That is what I call GREAT research!!!!!!!!!!!! | netcurtains | |
19/2/2020 10:15 | Lol. Yes indeed.That research note is very good tho :) | herschel k | |
19/2/2020 10:10 | Well done.....I seem to remember a similar exchange in early October! | langland | |
19/2/2020 09:57 | Not at all.Just nothing to say here.Sp swings on AOR are always big because there are so few shares in circulation.Holding for the end game. Whenever that comes | herschel k | |
19/2/2020 09:49 | Quiet start on the board this AM despite release of research note. I am guessing a few sold out during the recent decline. | langland | |
19/2/2020 08:58 | Good note - hopefully drum up some more interest. | someuwin | |
19/2/2020 08:51 | Detailed 16 page initiation from Dr Andy Smith at Equity Development , freely available here : Concludes: After many years in the making, AorTech is now in the right place at the right time – as demonstrated by the many historical transactions that have taken place in the heart valve and graft space – for the company to generate significant value. Our sum of the parts valuation for AorTech suggests that there could be much further to run than in the share price appreciation in the last year as this value becomes recognised. We value AorTech at £99.2m or 676p per share. | edmonda | |
19/2/2020 08:19 | New note from Equity Development valued AOR at 676p!! Analyst Andy Smith a veteran of life sciences sector so knows the business area well. | landy90 | |
18/2/2020 17:32 | A more positive day tomorrow? | landy90 | |
18/2/2020 16:43 | In case anyone is wondering about the apparent continued selling, today’s trades at 75.55 (2k) and 75.75 (7.5k) were certainly purchases. I was watching the quotes online and those prices were available at the relevant times. I could still buy small amounts at 77 near the close although larger amounts above 20k are quoted nearer 80. You never know when people are going to sell in the future but these could have been bargain buys today, who can say? | bones | |
17/2/2020 13:15 | If you are looking to pass the time of day, there was a new programme of “Hospital&rdqu It contains a few minutes of operation footage between minutes 7 and 12 (if you don’t mind seeing live human innards being removed) of a patient that has suffered an aortic aneurysm and has part of his aorta removed and a fabric tube (or graft?) inserted in its place. If I am not mistaken, this type of surgical device is what Aortech/RUA Medical are currently working on. The one used in the BBC programme is presumably sealed with animal-derived by-products and it is Aortech’s intention to introduce such devices sealed by Elast-Eon polymer, thereby negating the need to rely on abattoir-sourced material. | bones | |
15/2/2020 07:06 | The share-price is behaving very well IMHO it gives the long-term investor a chance to top up on any pullback, bones has it spot on above. | parsons4 | |
14/2/2020 17:45 | thanks Bones! | netcurtains | |
14/2/2020 17:32 | NET IS WELL WORTH FILTERING | toffeeman | |
14/2/2020 17:09 | Put it this way, Net, barely 1% of the company’s shares changed hands over last two weeks IN TOTAL. 60k bought, 110k sold approximately, most buyers picking up potential bargains in the 80p region. Sellers have been dropping out small amounts daily as the MM’s marked prices down after each one. Bit of a shake down there. I would expect a similar multiplier effect on share price movement in the event of positive sentiment, whenever that comes. Let’s hope Bill Brown and David Richmond have had a decent week in California! | bones | |
13/2/2020 11:48 | Is AOR a falling knife or is AOR a fallen knife; ready to be picked up? Do any of you chart people know? | netcurtains | |
13/2/2020 08:33 | Clickbait above | nik7907 | |
13/2/2020 08:26 | US biotech/medtech sector strong UK biotech/medtech sector weak Woodford and Brexit have a lot to answer for Eventually value will out | the stigologist | |
12/2/2020 15:38 | Reached 50% retracement level. | langland | |
12/2/2020 15:11 | Lots of small pharma getting hammered at the moment. | ewanwhose | |
12/2/2020 12:02 | Judging by recent trade activity, it seems as though boredom has set in with some of our shareholders. One thing longer term AOR shareholders do not lack is longer term patience!! | bones | |
12/2/2020 09:22 | They might make the odd pizza that can be slid under the door to give elderly some nourishment. | coolhandfluke | |
11/2/2020 10:08 | Does anyone know if AOR make anything that would benefit any of the elderly patients that have Coronavirus and might get damaged lungs/heart etc? | netcurtains |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions